Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Colburn

Showing results (51-60 of 194) with videos related to

Pageof 20
Sort By:
Hospital Formulary|April 9, 1988
Recent advances in communicable disease prevention: hepatitis B, pneumococcus, and H influenzae type bP A Colburn, M B Ross
Clinical Pharmacokinetics|September 10, 2003
Biomarkers, validation and pharmacokinetic-pharmacodynamic modellingWayne A Colburn, Jean W Lee
Journal of Toxicology and Environmental Health|January 1, 1985
Pharmacokinetic model to describe the disposition of lead in the ratL D Bornemann, W A Colburn
Journal of Clinical Pharmacology|May 1, 1996
Who is responsible for clinical pharmacology?W A Colburn, D L Keefe
Life Sciences|January 8, 1979
Effect of specific antisera on the redistribution of chlorinated biphenyls in the mouseW A Colburn, C M White
Clinical Pharmacy|July 1, 1990
Clinical uses of intravenous immune globulinM J Knapp, P A Colburn
Toxicology and Applied Pharmacology|May 1, 1979
Pharmacokinetics in the interpretation of chronic toxicity tests: the last-in, first-out phenomenonW A Colburn, H B Matthews
Journal of Pharmaceutical Sciences|November 1, 1984
Composite pharmacokinetic profilingW A Colburn, D M Gibson
Therapeutic Drug Monitoring|January 1, 1983
Multiple-dose pharmacokinetics of diazepam following once-daily administration of a controlled-release capsuleR J Wills, W A Colburn
Clinical Pharmacology and Therapeutics|April 1, 1985
Isotretinoin kinetics after 80 to 320 mg oral dosesW A Colburn, D M Gibson
Pageof 20

Showing results (51-60 of 194) with videos related to

Sort By:
Pageof 20
Hospital Formulary|April 9, 1988
Recent advances in communicable disease prevention: hepatitis B, pneumococcus, and H influenzae type bP A Colburn, M B Ross
Clinical Pharmacokinetics|September 10, 2003
Biomarkers, validation and pharmacokinetic-pharmacodynamic modellingWayne A Colburn, Jean W Lee
Journal of Toxicology and Environmental Health|January 1, 1985
Pharmacokinetic model to describe the disposition of lead in the ratL D Bornemann, W A Colburn
Journal of Clinical Pharmacology|May 1, 1996
Who is responsible for clinical pharmacology?W A Colburn, D L Keefe
Life Sciences|January 8, 1979
Effect of specific antisera on the redistribution of chlorinated biphenyls in the mouseW A Colburn, C M White
Clinical Pharmacy|July 1, 1990
Clinical uses of intravenous immune globulinM J Knapp, P A Colburn
Toxicology and Applied Pharmacology|May 1, 1979
Pharmacokinetics in the interpretation of chronic toxicity tests: the last-in, first-out phenomenonW A Colburn, H B Matthews
Journal of Pharmaceutical Sciences|November 1, 1984
Composite pharmacokinetic profilingW A Colburn, D M Gibson
Therapeutic Drug Monitoring|January 1, 1983
Multiple-dose pharmacokinetics of diazepam following once-daily administration of a controlled-release capsuleR J Wills, W A Colburn
Clinical Pharmacology and Therapeutics|April 1, 1985
Isotretinoin kinetics after 80 to 320 mg oral dosesW A Colburn, D M Gibson
Pageof 20